Skip to content

Andrew Guggenhime, President and CFO at Vaxcyte, sold PCVX on Jul 6, 2026

Data as of Oct 16

▼ SELL$452K7,913 shares at $57.16Andrew Guggenhime President and CFOPCVX Vaxcyte, Inc.
Watch PCVX
Traded
Jul 6, 2026
Disclosed
Jul 6, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Andrew Guggenhime, President and CFO at Vaxcyte, sold PCVX on Jul 6, 2026TRADEDDISCLOSED
PCVXSimilar stocks (XLV — its sector index fund), rebased to PCVX's price on the disclosure day
PCVX since disclosure
+11.7%
after the sale
Similar stocks (XLV) since disclosure
+9.1%
XLV — its sector index fund

Change in closing price from Jul 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAndrew Guggenhime President and CFOPCVX Vaxcyte, Inc.$121Kdisclosed Jul 6 · filed the same day

See every trade on PCVX →